Bunsua, Merly L.

HRN: 29-05-76  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/22/2026
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
05/22/2026
05/29/2026
IVTT
4.5
Q8H
INFECTED WOUND
Checking Initial Appropriateness 
05/22/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
05/22/2026
05/29/2026
IVTT
600mg
Q8H
Infected Wound
Checking Initial Appropriateness 
06/20/2026
AMPICILLIN 1GM + SULBACTAM 500MG (VIAL)
06/20/2026
06/27/2026
IV
1.5g
Q6hrs
Breast Mass Left
Checking Initial Appropriateness 
06/20/2026
CLINDAMYCIN 150MG/ML, 4ML (AMP)
06/20/2026
06/27/2026
IV
600mg
Q6hrs
Breast Mass Left
Checking Initial Appropriateness 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: